Daiichi Sankyo begins oncology therapy trial for metastatic tumours
Daiichi Sankyo has dosed the first patient in a first-in-human global Phase I trial to...
Pfizer and BioNTech initiate trials of Covid-19 vaccine in Japan
Pfizer and BioNTech have begun combined Phase I and Phase II clinical trials of their...
Astex trials of guadecitabine for leukaemia fail to meet primary end point
Astex Pharmaceuticals has reported that Phase III trials of guadecitabine (sSGI-110) failed to meet the...
Takeda reports positive interim data from trial of Entyvio
Takeda Pharmaceutical has reported positive interim results from the VISIBLE open-label extension (OLE) trial of...
Seattle Genetics-Astellas’ Padcev meets primary goal in urothelial cancer
Seattle Genetics and Astellas Pharma have reported that Padcev (enfortumab vedotin-ejfv) achieved its primary endpoint...
Daiichi Sankyo to test patritumab deruxtecan for colorectal cancer
Daiichi Sankyo has started dosing patients in a Phase II clinical trial of patritumab deruxtecan...
Takeda’s Ninlaro misses primary goal in multiple myeloma trial
Takeda Pharmaceutical has reported results from the Phase III TOURMALINE-MM2 clinical trial of Ninlaro (ixazomib)...
Takeda’s soticlestat reduces seizures in Dravet syndrome trial
Takeda Pharmaceutical and Ovid Therapeutics have reported positive top-line data from the Phase II ELEKTRA...
Daiichi Sankyo and AstraZeneca partner on lung cancer trial
Daiichi Sankyo and AstraZeneca have partnered to assess patritumab deruxtecan (U3-1402) in combination with Tagrisso...
Eisai and Biogen launch Phase III preclinical Alzheimer’s study
Eisai, Biogen and the Alzheimer's Clinical Trials Consortium (ACTC) have initiated a new Phase III...